Unravelling the neural correlates of visual cueing in Parkinson’s disease
Objective: Visual cueing can compensate for impaired automatic gait control in Parkinson's disease (PD) patients experiencing Freezing of Gait (FOG) by engaging goal-directed motor behaviour1.…Disrupted Sleep and Daytime Sleepiness are Associated With Poorer Quality of Life in Advanced Parkinson’s Disease: ROSSINI Interim Results
Objective: To evaluate correlations between real-world (RW) improvements in Parkinson’s disease (PD)-related sleep disturbances with foslevodopa/foscarbidopa (LDp/CDp) treatment, daytime sleepiness, and quality of life (QoL).…Beyond Motor Outcomes: Health Literacy, Medication Adherence, and Quality of Life in Parkinson’s Disease Patients Undergoing the Levodopa Challenge Test
Objective: To characterize health literacy (HL), medication adherence, satisfaction with medication information, and quality of life (QoL) in Parkinson’s disease (PD) patients undergoing the levodopa…Dopaminergic reconfiguration of an inverted network hierarchy in Parkinson’s disease
Objective: To determine how acute dopaminergic treatment reshapes large-scale brain network organization in Parkinson’s disease (PD). Background: Dopamine replacement reliably improves motor symptoms in PD,…The Sweet Smell of ON: Phantosmia During Motor Fluctuations After Initiation of Foslevodopa/Foscarbidopa Infusion Therapy
Objective: To report a unique case of phantosmia/olfactory hallucinations (OfH) emerging as a non-motor fluctuation after initiation of foslevodopa/foscarbidopa (LDp/CDp) infusion at a lower levodopa…Characterizing Longitudinal Motor Progression in Parkinson’s Disease leveraging Digital Health Technologies in L-DOPA ON and OFF States
Objective: To characterize the longitudinal motor progression of Parkinson’s disease (PD) over 104 weeks both in practically defined on and off medication states using a…Continuous Subcutaneous Foslevodopa/Foscarbidopa After Deep Brain Stimulation or Levodopa–Carbidopa Intestinal Gel: A Case Series in Advanced Parkinson’s Disease
Objective: To describe indications and short-term outcomes of FLC/FCD in PD patients previously treated with DBS and/or LCIG. Background: Advanced Parkinson's disease patients treated with…Levodopa-Induced Dyskinesias in Patients with Parkinson’s Disease in the Uzbek Population
Objective: To investigate the clinical features and prevalence of levodopa-induced dyskinesias in patients with Parkinson’s disease in the Uzbek population. Background: Levodopa-induced dyskinesias (LID) are…IPX203 Achieves High Responder Rates Independent of Fluctuation Severity: Insights From RISE‑PD
Objective: To evaluate responder rates for Good ON time and OFF time with IPX203 using PD diary data from the RISE-PD trial, including comparisons by…Levodopa Responsiveness and Motor Complication Trajectories in Parkinson’s Disease by α-Synuclein Seed Amplification Assay Status
Objective: To investigate whether longitudinal trajectories of medication responsiveness and motor complications differ based on cerebrospinal fluid α-synuclein seed amplification assay (CSF SAA) status in…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 70
- Next Page »